Tazibet Amine, Ortmans Staniel, Potelle Charlotte, Marquie Christelle, Klein Cédric, Guedon Laurence, Verbrugge Eric, Kouakam Claude, Brigadeau François, Klug Didier, Ninni Sandro
CHU de Lille, boulevard Jules-Leclercq, 59000 Lille, France.
CHU de Lille, boulevard Jules-Leclercq, 59000 Lille, France.
Arch Cardiovasc Dis. 2025 Jun 19. doi: 10.1016/j.acvd.2025.06.003.
Improvements in pharmacological treatments and cardiac resynchronization therapy (CRT) raise questions about the benefit of implantable cardioverter defibrillators (ICDs) in non-ischaemic dilated cardiomyopathy (NI-DCM). In this context, the long-term incidence of ventricular arrhythmia events (VAEs) by response to CRT remains under-reported.
To assess the long-term risk of VAE by response to CRT in patients with NI-DCM.
Patients who underwent CRT-defibrillator (CRT-D) implantation for primary prevention of NI-DCM (left ventricular ejection fraction [LVEF]≤35%, bundle branch block>130ms) from February 2002 to January 2020 were retrospectively included. CRT response was defined as an increase in LVEF≥10%, with LVEF≥35% at first transthoracic echocardiography (TTE) evaluation. VAE was defined as a sudden arrhythmic death, sustained ventricular arrhythmia or device-treated ventricular arrhythmia, occurring after the first TTE evaluation.
A total of 192 patients (mean age 61years, 68% female, mean LVEF 25%) were included and followed for a median of 91months. Median time to first TTE evaluation after CRT-D implantation was 14months. The overall incidence of VAE was 18.8% (annual rate of 2.9%). CRT response was associated with a reduced risk of VAE (hazard ratio [HR]: 0.27, 95% CI: 0.14-0.55; P<0.001). Super responders to CRT had a lower risk of VAE compared to partial responders (HR: 0.06, 95% CI: 0.02-0.17; P<0.001). Among responders who were VAE free before generator replacement, super responders exhibited a lower incidence of VAE compared to partial responders (HR: 0.13, 95% CI: 0.02-0.82; P=0.04) after generator replacement.
In patients with NI-DCM undergoing CRT-D implantation for primary prevention, the CRT response was associated with a 73% decrease in the risk of VAE. Partial responders present a higher rate of VAE compared to super responders, persisting after generator replacement.
药物治疗和心脏再同步治疗(CRT)的进展引发了关于植入式心脏复律除颤器(ICD)在非缺血性扩张型心肌病(NI-DCM)中的获益问题。在此背景下,CRT反应导致的室性心律失常事件(VAE)的长期发生率仍报道不足。
评估NI-DCM患者中CRT反应导致的VAE的长期风险。
回顾性纳入2002年2月至2020年1月因NI-DCM一级预防(左心室射血分数[LVEF]≤35%,束支传导阻滞>130ms)而接受CRT除颤器(CRT-D)植入的患者。CRT反应定义为LVEF增加≥10%,首次经胸超声心动图(TTE)评估时LVEF≥35%。VAE定义为首次TTE评估后发生的心脏性猝死、持续性室性心律失常或器械治疗的室性心律失常。
共纳入192例患者(平均年龄61岁,68%为女性,平均LVEF 为25%),中位随访91个月。CRT-D植入后至首次TTE评估的中位时间为14个月。VAE的总体发生率为18.8%(年发生率为2.9%)。CRT反应与VAE风险降低相关(风险比[HR]:0.27,95%可信区间[CI]:0.14 - 0.55;P<0.001)。与部分反应者相比,CRT的超反应者发生VAE的风险更低(HR:0.06,95%CI:0.02 - 0.17;P<0.001)。在发生器更换前无VAE的反应者中,与部分反应者相比,超反应者在发生器更换后VAE的发生率更低(HR:0.13,95%CI:0.02 - 0.82;P = 0.04)。
在因一级预防接受CRT-D植入的NI-DCM患者中,CRT反应与VAE风险降低73%相关。与超反应者相比,部分反应者的VAE发生率更高,且在发生器更换后仍持续存在。